Investors.vrtx.com

Vertex Announces US FDA Approval of CASGEVY™ …

Web- Approximately 1,000 patients in the U.S. 12 years of age and older are now eligible for this one-time treatment -. BOSTON--(BUSINESS WIRE)--Jan. 16, 2024-- …

Actived: 8 days ago

URL: https://investors.vrtx.com/news-releases/news-release-details/vertex-announces-us-fda-approval-casgevytm-exagamglogene

Vertex Announces Further Expansion in the Boston Seaport at …

Web-New 344,000 square foot cell and genetic therapies research and manufacturing facility to be built--Facility to support continued R&D growth-BOSTON- …

Category: Health Go Health

Vertex Announces $50 Million Commitment to Health Equity With …

Web– Vertex grant to JDRF supports efforts to improve clinical trial diversity in type 1 diabetes – – The Vertex Foundation grant supports the Mass General …

Category: Health Go Health

The Vertex Foundation Donates $500,000 to Partners HealthCare …

WebBOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the Vertex Foundation, a nonprofit charitable …

Category: Health Go Health

Vertex and CRISPR Therapeutics Announce US FDA Approval of …

Web–First-ever approval of a CRISPR-based gene-editing therapy in the U.S. – – Approximately 16,000 patients 12 years of age and older with severe sickle cell disease …

Category: Health Go Health

Vertex and the Vertex Foundation Commit $4 Million to Support …

Web-Vertex Foundation Announces $1.5 Million Gift to Boston University’s New Center for Antiracist Research--Biotechnology-focused curriculum established in …

Category: Health Go Health

Health Canada Grants Market Authorization for KALYDECO® …

Web-KALYDECO is the first and only approved medicine in Canada to treat the underlying cause of cystic fibrosis in these young patients-. BOSTON--(BUSINESS …

Category: Medicine Go Health

Health Canada Approves KALYDECO™ (ivacaftor), the First …

Web-- Approximately 100 people in Canada have the G551D mutation in the CFTR gene ---- First medicine resulting from 1989 co-discovery of CF gene by researchers in …

Category: Medicine Go Health

Vertex Announces Approval of First CRISPR/Cas9 Gene-Edited …

Web- CASGEVY™ is first medicine ever to be evaluated through the SFDA’s Breakthrough Medicines Program - - First treatment center in Saudi Arabia has been …

Category: Medicine Go Health

Vertex and CRISPR Therapeutics Announce Authorization of the …

WebFirst regulatory authorization of a CRISPR-based gene-editing therapy in the world – - CASGEVY is indicated for the treatment of sickle cell disease in patients 12 …

Category: Health Go Health

Health Canada Grants Marketing Authorization for TRIKAFTA® …

WebThe Investor Relations website contains information about Vertex Pharmaceuticals's business for stockholders, potential investors, and financial analysts.

Category: Health Go Health

Vertex Names Dr. Alan Garber, Provost of Harvard University, to its

WebBOSTON--(BUSINESS WIRE)-- Shareholders of Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today elected Alan M. Garber, M.D., Ph.D. as an …

Category: Health Go Health

Vertex Provides Pipeline and Business Updates in Advance of …

WebBOSTON--(BUSINESS WIRE)--Jan. 7, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced multiple program updates ahead of …

Category: Health Go Health

Vertex to Present at the 42nd Annual J.P. Morgan Healthcare …

WebBOSTON--(BUSINESS WIRE)--Dec. 18, 2023-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Dr. Reshma Kewalramani, Chief …

Category: Health Go Health

Vertex to Present New Data on Exagamglogene Autotemcel (exa …

WebThe Investor Relations website contains information about Vertex Pharmaceuticals's business for stockholders, potential investors, and financial analysts.

Category: Health Go Health

Vertex Appoints Michel Lagarde to its Board of Directors Vertex

WebBOSTON--(BUSINESS WIRE)--Oct. 5, 2023-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Michel Lagarde has been appointed …

Category: Health Go Health

Vertex to Present at Cowen’s 43rd Annual Health Care Conference …

WebBOSTON--(BUSINESS WIRE)--Feb. 21, 2023-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will present at …

Category: Health Go Health

Positive Results from Pivotal Trials of CASGEVY™ (exagamglogene

Web- Longer-term follow-up data demonstrate consistent and durable response to treatment - BOSTON--(BUSINESS WIRE)--Dec. 11, 2023-- Vertex Pharmaceuticals …

Category: Health Go Health